Analysed PHIO PHARMACEUTICALS CORP (PHIO:NASDAQ) News Sources
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
26-06-2026
yahoo.com
Phio Pharmaceuticals Expands Global Patent Portfolio With New International Patent Milestones
15-07-2026
advfn.com
Phio Pharmaceuticals Announces Appointment of Dr. R. Todd Plott to the Board of Directors
21-07-2026
yahoo.com
Correction to Announcement Regarding Phio Pharmaceuticals Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
22-07-2026
yahoo.com
Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
06-08-2026
yahoo.com
Phio Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
11-09-2026
yahoo.com
Phio Announces Key Development Milestone for PH-762 with FDA Submission Supporting Next Stage of Clinical Development in Cutaneous Squamous Cell Carcinoma
14-09-2026
yahoo.com
Phio Pharmaceuticals to Present Clinical Development Update and Upcoming Catalysts at Life Sciences Future 2026 Conference
23-09-2026
yahoo.com
Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference
05-10-2026
yahoo.com
What is the current price of PHIO PHARMACEUTICALS CORP (PHIO:NASDAQ)?
The current price of PHIO PHARMACEUTICALS CORP (PHIO:NASDAQ) is $0.9788.
PHIO PHARMACEUTICALS CORP (PHIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of PHIO PHARMACEUTICALS CORP (PHIO:NASDAQ) since the previous trading day is $0.0057.
PHIO PHARMACEUTICALS CORP (PHIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of PHIO PHARMACEUTICALS CORP (PHIO:NASDAQ) since the previous trading day is 0.5858%.
What is the most recent average sentiment score for PHIO PHARMACEUTICALS CORP (PHIO:NASDAQ)?
The most recent average sentiment score for PHIO PHARMACEUTICALS CORP (PHIO:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for PHIO PHARMACEUTICALS CORP (PHIO:NASDAQ)?
The most recent sentiment for PHIO PHARMACEUTICALS CORP (PHIO:NASDAQ) is .
SEC-8K** Filing Available For PHIO PHARMACEUTICALS CORP (PHIO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.